UNICK FIX-A-FORM AND PRINTERS | SHUKRA PHARMA | UNICK FIX-A-FORM AND PRINTERS/ SHUKRA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.9 | 21.6 | 129.2% | View Chart |
P/BV | x | 1.1 | 15.8 | 7.2% | View Chart |
Dividend Yield | % | 0.0 | 0.5 | - |
UNICK FIX-A-FORM AND PRINTERS SHUKRA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
SHUKRA PHARMA Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ SHUKRA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 89 | 66.6% | |
Low | Rs | 32 | 11 | 283.3% | |
Sales per share (Unadj.) | Rs | 120.5 | 53.7 | 224.5% | |
Earnings per share (Unadj.) | Rs | 4.1 | 4.0 | 101.5% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 5.7 | 196.9% | |
Dividends per share (Unadj.) | Rs | 0 | 0.50 | 0.0% | |
Avg Dividend yield | % | 0 | 1.0 | 0.0% | |
Book value per share (Unadj.) | Rs | 53.9 | 23.1 | 233.5% | |
Shares outstanding (eoy) | m | 5.49 | 10.96 | 50.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 0.9 | 40.4% | |
Avg P/E ratio | x | 11.1 | 12.4 | 89.2% | |
P/CF ratio (eoy) | x | 4.0 | 8.8 | 46.0% | |
Price / Book Value ratio | x | 0.8 | 2.2 | 38.8% | |
Dividend payout | % | 0 | 12.4 | 0.0% | |
Avg Mkt Cap | Rs m | 248 | 547 | 45.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 44 | 203.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 588 | 112.5% | |
Other income | Rs m | 5 | 12 | 42.7% | |
Total revenues | Rs m | 667 | 600 | 111.1% | |
Gross profit | Rs m | 88 | 54 | 163.6% | |
Depreciation | Rs m | 39 | 18 | 213.1% | |
Interest | Rs m | 24 | 3 | 847.7% | |
Profit before tax | Rs m | 30 | 44 | 67.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 0 | 2,134.3% | |
Profit after tax | Rs m | 22 | 44 | 50.9% | |
Gross profit margin | % | 13.3 | 9.1 | 145.5% | |
Effective tax rate | % | 25.0 | 0.8 | 3,155.0% | |
Net profit margin | % | 3.4 | 7.5 | 45.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 531 | 56.7% | |
Current liabilities | Rs m | 287 | 425 | 67.5% | |
Net working cap to sales | % | 2.1 | 18.0 | 11.8% | |
Current ratio | x | 1.0 | 1.2 | 84.0% | |
Inventory Days | Days | 4 | 0 | - | |
Debtors Days | Days | 72,349,839 | 1,873 | 3,863,291.2% | |
Net fixed assets | Rs m | 402 | 219 | 183.4% | |
Share capital | Rs m | 55 | 39 | 140.1% | |
"Free" reserves | Rs m | 241 | 214 | 112.7% | |
Net worth | Rs m | 296 | 253 | 117.0% | |
Long term debt | Rs m | 89 | 38 | 235.5% | |
Total assets | Rs m | 705 | 750 | 94.1% | |
Interest coverage | x | 2.3 | 16.8 | 13.4% | |
Debt to equity ratio | x | 0.3 | 0.1 | 201.3% | |
Sales to assets ratio | x | 0.9 | 0.8 | 119.5% | |
Return on assets | % | 6.6 | 6.3 | 104.8% | |
Return on equity | % | 7.6 | 17.4 | 43.5% | |
Return on capital | % | 14.0 | 16.2 | 85.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 32 | 137.8% | |
From Investments | Rs m | -27 | -44 | 61.0% | |
From Financial Activity | Rs m | -16 | 49 | -33.0% | |
Net Cashflow | Rs m | 0 | 37 | 1.0% |
Indian Promoters | % | 71.6 | 51.0 | 140.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 0.1 | 409.1% | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 49.0 | 58.0% | |
Shareholders | 1,622 | 12,974 | 12.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | RELISH PHARMA | S&P BSE TECK |
---|---|---|---|
1-Day | 0.00% | -1.98% | 0.13% |
1-Month | 21.23% | 14.40% | -1.23% |
1-Year | 60.49% | 261.95% | 26.40% |
3-Year CAGR | 30.30% | 158.62% | 10.31% |
5-Year CAGR | 21.81% | 96.02% | 14.89% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the RELISH PHARMA share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of RELISH PHARMA the stake stands at 51.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of RELISH PHARMA.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
RELISH PHARMA paid Rs 0.5, and its dividend payout ratio stood at 12.4%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of RELISH PHARMA.
For a sector overview, read our media sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.